Peter Kelley

536 total citations
17 papers, 364 citations indexed

About

Peter Kelley is a scholar working on Epidemiology, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, Peter Kelley has authored 17 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Clinical Biochemistry and 5 papers in Infectious Diseases. Recurrent topics in Peter Kelley's work include Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Use and Resistance (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Peter Kelley is often cited by papers focused on Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Use and Resistance (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Peter Kelley collaborates with scholars based in Australia, United States and Vietnam. Peter Kelley's co-authors include Benjamin P. Howden, Wei Gao, Peter Ward, David Gordon, Peter D. Cooper, Nikolai Petrovsky, Susanne Heinzel, Elizabeth A. Grabsch, M. Lindsay Grayson and Emma Bishop and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy and Journal of General Virology.

In The Last Decade

Peter Kelley

17 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Kelley Australia 9 208 143 111 75 54 17 364
Rita Dhar Kuwait 13 288 1.4× 223 1.6× 80 0.7× 90 1.2× 23 0.4× 29 443
Hideji Yanagisawa Japan 12 138 0.7× 143 1.0× 115 1.0× 90 1.2× 116 2.1× 19 376
Michel Auzou France 14 204 1.0× 117 0.8× 149 1.3× 109 1.5× 45 0.8× 24 422
H. Aubry‐Damon France 7 268 1.3× 86 0.6× 114 1.0× 140 1.9× 42 0.8× 10 414
P. Gialanella United States 11 297 1.4× 167 1.2× 95 0.9× 94 1.3× 42 0.8× 12 406
Daniela Barbarini Italy 12 191 0.9× 130 0.9× 183 1.6× 122 1.6× 54 1.0× 27 499
Hye Ran Kim South Korea 13 154 0.7× 143 1.0× 108 1.0× 89 1.2× 40 0.7× 23 391
Mohamed Tazir Algeria 10 211 1.0× 70 0.5× 87 0.8× 141 1.9× 46 0.9× 11 348
María Eliecer Cano Spain 10 104 0.5× 111 0.8× 75 0.7× 73 1.0× 31 0.6× 14 463
Ron Bosboom Netherlands 13 150 0.7× 230 1.6× 129 1.2× 81 1.1× 41 0.8× 17 465

Countries citing papers authored by Peter Kelley

Since Specialization
Citations

This map shows the geographic impact of Peter Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kelley more than expected).

Fields of papers citing papers by Peter Kelley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kelley. The network helps show where Peter Kelley may publish in the future.

Co-authorship network of co-authors of Peter Kelley

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kelley. A scholar is included among the top collaborators of Peter Kelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kelley. Peter Kelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Daniel, Diane, Louise M. Judd, Ryan R. Wick, et al.. (2025). Genomics to understand the global landscape of linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Microbial Genomics. 11(6). 5 indexed citations
2.
Muhi, Stephen, Justina H. Hill, Anthony McDonald, et al.. (2025). Management of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: consensus statement. The Medical Journal of Australia. 222(11). 571–578. 1 indexed citations
3.
Graham, Maryza, Louise Cooley, Peter Kelley, et al.. (2022). Establishment of RCPA national guidelines for selective reporting of antimicrobials: processes, challenges and measuring the impact. Journal of Antimicrobial Chemotherapy. 77(11). 3064–3068. 1 indexed citations
4.
Kelley, Peter, et al.. (2021). Multiplex RT-PCR provides improved diagnosis of skin and nail dermatophyte infections compared to microscopy and culture: a laboratory study and review of the literature. Diagnostic Microbiology and Infectious Disease. 101(3). 115413–115413. 22 indexed citations
5.
Graudins, Linda V, Douglas Johnson, Evan Newnham, et al.. (2020). A Survey on Knowledge Gaps in Assessment and Management of Severe Drug Hypersensitivity Reactions: Multicenter Cross‐Sectional Study of Australian Health Care Providers. The Journal of Clinical Pharmacology. 61(1). 25–31. 5 indexed citations
6.
Kelley, Peter, et al.. (2019). Eumycetoma diagnosed in urban Australia. The Medical Journal of Australia. 212(3). 107–107. 1 indexed citations
7.
Kelley, Peter, et al.. (2019). Diagnosis of skin and nail dermatophyte infections using multiplex PCR. Pathology. 51. S138–S138. 1 indexed citations
9.
Tay, Ee Laine, Andrew J. Stewardson, Peter Kelley, et al.. (2017). The location of Australian Buruli ulcer lesions—Implications for unravelling disease transmission. PLoS neglected tropical diseases. 11(8). e0005800–e0005800. 27 indexed citations
10.
Cairns, Kelly A., Joseph Doyle, Janine M. Trevillyan, et al.. (2016). The impact of a multidisciplinary antimicrobial stewardship team on the timeliness of antimicrobial therapy in patients with positive blood cultures: a randomized controlled trial. Journal of Antimicrobial Chemotherapy. 71(11). 3276–3283. 32 indexed citations
11.
Gordon, David, Peter Kelley, Susanne Heinzel, Peter D. Cooper, & Nikolai Petrovsky. (2014). Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study. Vaccine. 32(48). 6469–6477. 78 indexed citations
12.
Kelley, Peter. (2014). Antimicrobial stewardship: the role of the clinical microbiology service. Pathology. 46. S45–S45. 2 indexed citations
13.
Kelley, Peter, Elizabeth A. Grabsch, Shirley Xie, et al.. (2011). Evaluation of the Xpert™ MRSA/SA Blood Culture assay for the detection of Staphylococcus aureus including strains with reduced vancomycin susceptibility from blood culture specimens. Diagnostic Microbiology and Infectious Disease. 70(3). 404–407. 20 indexed citations
14.
Kelley, Peter, Wei Gao, Peter Ward, & Benjamin P. Howden. (2011). Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure. Journal of Antimicrobial Chemotherapy. 66(5). 1057–1060. 75 indexed citations
15.
Kelley, Peter, Elizabeth A. Grabsch, Benjamin P. Howden, Wei Gao, & M. Lindsay Grayson. (2009). Comparison of the Xpert Methicillin-Resistant Staphylococcus aureus (MRSA) Assay, BD GeneOhm MRSA Assay, and Culture for Detection of Nasal and Cutaneous Groin Colonization by MRSA. Journal of Clinical Microbiology. 47(11). 3769–3772. 38 indexed citations
16.
Swaminathan, Sanjay, Peter Kelley, Michael Ahern, & David Gordon. (2007). Acute cytomegalovirus infection presenting with severe vulvar swelling. International Journal of Gynecology & Obstetrics. 99(2). 133–134. 5 indexed citations
17.
Kelley, Peter, et al.. (2001). Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus. Journal of General Virology. 82(7). 1647–1656. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026